510(k) Report

FDA applicant

Amedica Biotech, Inc.

Hayward, CA13 decisions2002–20102 recalls

FDA records 13 decisions for Amedica Biotech, Inc. (Hayward, CA) from 2002 to 2010: 13 510(k) clearances. Most are in product codes LDJ (Enzyme Immunoassay, Cannabinoids) and DKZ (Enzyme Immunoassay, Amphetamine). 2 recalls are linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical toxicology panel, where it files most

How often FDA has decided Amedica Biotech, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2010

2008: 22010: 1
2007high 2 (2008) · low 0 (2007)2026

2026 so far, outlined.

Recalls per year

1in 2017

2016: 12017: 1
2007high 1 (2016) · low 0 (2007)2026

Class I Class II/III not classified

FIG. 1 — Amedica Biotech, Inc. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Amedica Biotech, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Amedica”

FDA records each applicant name separately; these may or may not be the same firm.